Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

4 Biotechs Struggling Due To High Drug Costs
Seeking Alpha
Thursday, April 5, 2012 - 9:14pm
tags:
Pfizer, Dendreon, Cell Therapeutics, Exelixis
Krill Oil Based Drug Candidate Could Unseat Glaxo's Blockbuster Loveza
Seeking Alpha
Thursday, April 5, 2012 - 9:13pm
tags:
GSK, Loveza, krill oil, Pfizer, Neptune Biopharma, Acasti
Priority Review for Zaltrap
Yahoo/Zacks
Thursday, April 5, 2012 - 9:12pm
tags:
Zaltrap, Regeneron, Sanofi, colorectal cancer
Vivus' ED Drug Will Make Investors Money
Motley Fool
Thursday, April 5, 2012 - 9:11pm
tags:
erectile dysfunction, Vivus, Avanafil
Expensive Celgene Shares A Better Bet Than Most Biotechs
Seeking Alpha
Thursday, April 5, 2012 - 9:10pm
tags:
Celgene, JNJ, ONYX Pharmaceuticals, Revlimid, Pfizer
Astellas Wins FDA Panel Backing for Overactive Bladder Drug
Bloomberg
Thursday, April 5, 2012 - 9:07pm
tags:
FDA, overactive bladder, Astellas, mirabegron
Teva Active on the Generics Front
Yahoo/Zacks
Thursday, April 5, 2012 - 9:06pm
tags:
generics, Teva Pharmaceuticals, Sanofi, AstraZeneca, Avapro, Avalide, Lexapro, Forest Labs, Seroquel
Does Novo Nordisk's Pipeline Justify Its Premium?
Seeking Alpha
Thursday, April 5, 2012 - 9:04pm
tags:
Novo Nordisk
Lpath: A Solid Pipeline With Good PPS
Seeking Alpha
Thursday, April 5, 2012 - 7:38pm
tags:
Lpath, Pfizer, Merck, bioactive lipids
Pfizer Will Trim Benefits for Fired Workers in Cost-Cutting
Bloomberg
Thursday, April 5, 2012 - 7:37pm
tags:
Pfizer, severance
Allos to be acquired by Spectrum Pharma for $206M
Marketwatch
Thursday, April 5, 2012 - 8:42am
tags:
M&A, Spectrum Pharmaceuticals, Allos
Arena: Which Way, Up Or Down?
Seeking Alpha
Thursday, April 5, 2012 - 8:41am
tags:
Arena, obesity, lorcaserin
Myriad Study to Benefit Colaris
Yahoo/Zacks.com
Wednesday, April 4, 2012 - 11:22pm
tags:
Colaris, Myriad Genetics, colon cancer
U.S. drug spending up, thanks to new drug launches
Fierce Pharma
Wednesday, April 4, 2012 - 11:11pm
tags:
drug launches, prescription data
Idenix Drops as Hepatitis C Drug May Face Hurdles
Bloomberg
Wednesday, April 4, 2012 - 11:03pm
tags:
Idenix, hepatitis C, IDX184, Roche
Vaccines alliance nears deal on cervical cancer shots
Reuters
Wednesday, April 4, 2012 - 10:58pm
tags:
vaccines, cervical cancer, Merck, Gardasil, HPV, GAVI, GSK
Pfizer: A Compelling Buy Candidate In 2012
Seeking Alpha
Wednesday, April 4, 2012 - 10:56pm
tags:
Pfizer, Abbott Laboratories, Bristol-Myers Squibb, GSK, Merck, Mead Johnson Nutrition
Biogen reaches all-time highs and gets upgrade
Yahoo/AP
Wednesday, April 4, 2012 - 10:54pm
tags:
Biogen Idec
Focus On Upcoming FDA Drug Approval And Advisory Dates
Seeking Alpha
Wednesday, April 4, 2012 - 11:18am
tags:
FDA, XenoPort, Horizant, lorcaserin, Arena Pharmaceuticals, Qnexa, Vivus, Protalix BioTherapeutics, GSK, taliglucerase
Abbott Hepatitis C Therapy Works After Other Drugs Fail
Bloomberg
Wednesday, April 4, 2012 - 11:15am
tags:
Abbott Laboratories, hepatitis C, ABT-450, ABT-072

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.